The Impact of COVID-19 is included in Cell Free Fetal DNA Testing Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Cell Free Fetal DNA Testing Trends and Forecast
The future of the global cell free fetal DNA testing market looks promising with opportunities in the hospital and clinic center applications. The global cell free fetal DNA testing market is expected to grow with a CAGR of 12.3% from 2024 to 2030. The major drivers for this market are raising consciousness regarding genetic disorders and growing preference for secure and minimally risky prenatal diagnostic techniques in obstetrics.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cell Free Fetal DNA Testing by Segment
The study includes a forecast for the global cell free fetal DNA testing by type, application, and region.
Cell Free Fetal DNA Testing Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Abnormal Chromosome Number Detection
• Gender Testing
• Paternally Inherited Disorder Detection
• Paternity Testing
• Others
Cell Free Fetal DNA Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Hospital
• Clinic Center
• Others
Cell Free Fetal DNA Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Cell Free Fetal DNA Testing Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cell free fetal DNA testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cell free fetal DNA testing companies profiled in this report include-
• The Fetal Medicine Centre
• Apollo Path labs
• Ariosa Diagnostics
• Sequenom Laboratories
• Laboratory Corporation of America Holdings
• Personal Genome Diagnostics
• Premaitha Health
• Berry Genomics
• Roche Holdings
• Trovagene
Cell Free Fetal DNA Testing Market Insights
Lucintel forecasts that abnormal chromosome number detection is expected to witness highest growth over the forecast period due to its widespread use in detecting variety of chromosomal disorders.
North America is expected to witness highest growth over the forecast period due to existence of developed healthcare system and increasing frequency of various diseases linked to cell-free DNA testing among population of the region.
Features of the Global Cell Free Fetal DNA Testing Market
Market Size Estimates: Cell free fetal DNA testing market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cell free fetal DNA testing market size by type, application, and region in terms of value ($B).
Regional Analysis: Cell free fetal DNA testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the cell free fetal DNA testing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cell free fetal DNA testing market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for cell free fetal DNA testing market?
Answer: The global cell free fetal DNA testing market is expected to grow with a CAGR of 12.3% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the cell free fetal DNA testing market?
Answer: The major drivers for this market are raising consciousness regarding genetic disorders and growing preference for secure and minimally risky prenatal diagnostic techniques in obstetrics.
Q3. What are the major segments for cell free fetal DNA testing market?
Answer: The future of the cell free fetal DNA testing market looks promising with opportunities in the hospital and clinic center markets.
Q4. Who are the key cell free fetal DNA testing market companies?
Answer: Some of the key cell free fetal DNA testing companies are as follows:
• The Fetal Medicine Centre
• Apollo Path labs
• Ariosa Diagnostics
• Sequenom Laboratories
• Laboratory Corporation of America Holdings
• Personal Genome Diagnostics
• Premaitha Health
• Berry Genomics
• Roche Holdings
• Trovagene
Q5. Which cell free fetal DNA testing market segment will be the largest in future?
Answer: Lucintel forecasts that abnormal chromosome number detection is expected to witness highest growth over the forecast period due to its widespread use in detecting variety of chromosomal disorders.
Q6. In cell free fetal DNA testing market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to existence of developed healthcare system and increasing frequency of various diseases linked to cell-free DNA testing among population of the region.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cell free fetal DNA testing market by type (abnormal chromosome number detection, gender testing, paternally inherited disorder detection, paternity testing, and others), application (hospital, clinic center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Cell Free Fetal Dna Testing Market, Cell Free Fetal Dna Testing Market Size, Cell Free Fetal Dna Testing Market Growth, Cell Free Fetal Dna Testing Market Analysis, Cell Free Fetal Dna Testing Market Report, Cell Free Fetal Dna Testing Market Share, Cell Free Fetal Dna Testing Market Trends, Cell Free Fetal Dna Testing Market Forecast, Cell Free Fetal Dna Testing Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Cell Free Fetal DNA Testing Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cell Free Fetal DNA Testing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cell Free Fetal DNA Testing Market by Type
3.3.1: Abnormal Chromosome Number Detection
3.3.2: Gender Testing
3.3.3: Paternally Inherited Disorder Detection
3.3.4: Paternity Testing
3.3.5: Others
3.4: Global Cell Free Fetal DNA Testing Market by Application
3.4.1: Hospital
3.4.2: Clinic Center
3.4.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Cell Free Fetal DNA Testing Market by Region
4.2: North American Cell Free Fetal DNA Testing Market
4.2.2: North American Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
4.3: European Cell Free Fetal DNA Testing Market
4.3.1: European Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
4.3.2: European Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
4.4: APAC Cell Free Fetal DNA Testing Market
4.4.1: APAC Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
4.4.2: APAC Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
4.5: ROW Cell Free Fetal DNA Testing Market
4.5.1: ROW Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
4.5.2: ROW Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Type
6.1.2: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Application
6.1.3: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Region
6.2: Emerging Trends in the Global Cell Free Fetal DNA Testing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cell Free Fetal DNA Testing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell Free Fetal DNA Testing Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: The Fetal Medicine Centre
7.2: Apollo Path labs
7.3: Ariosa Diagnostics
7.4: Sequenom Laboratories
7.5: Laboratory Corporation of America Holdings
7.6: Personal Genome Diagnostics
7.7: Premaitha Health
7.8: Berry Genomics
7.9: Roche Holdings
7.10: Trovagene
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Cell Free Fetal DNA Testing Market Report.